Genoskin Overview

  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $61.6K
Latest Deal Amount
  • Investors
  • 5

Genoskin General Information


Developer and producer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmaceutical, cosmetical and chemical products. The company's technology permits for stable and long-term ex vivo cultivation of fresh human skin biopsies without loss of tissue integrity, morphology, physiology and cutaneous barrier function, enabling pharmaceutical and cosmetic products to test on real human tissue collected after surgery which is kept alive through an ex vivo culture system to avoid animal experiments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1, Place Pierre Potier
  • 31100 Toulouse
  • France
+33 09 00 00 00 00

Genoskin Timeline

Financing RoundFinancing Round
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Genoskin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 23-Mar-2018 $61.6K Completed Startup
4. Accelerator/Incubator 01-Jan-2018 Completed Startup
3. Accelerator/Incubator 01-Nov-2011 Completed Startup
2. Grant 28-Jun-2011 Completed Startup
1. Accelerator/Incubator 01-Sep-2009 Completed Startup
To view Genoskin’s complete valuation and funding history, request access »

Genoskin Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Developer and producer of ex vivo human skin models intended to facilitate the efficacy and toxicity testing of pharmace
Toulouse, France
4 As of 2015


quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure
Schlieren, Switzerland
00 As of 0000
0000 000.00

0000 000

iquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
Ecublens, Switzerland
0 As of 0000
0.000 0000-00-00
000000000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genoskin Competitors (18)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Formerly VC-backed Schlieren, Switzerland 00 000.00 0000 000.00
0000 0000000000 Venture Capital-Backed Ecublens, Switzerland 0 00.000 000000000 00.000
00000000 Corporation Alameda, CA 00 000000000 -
000000000 00000000 Corporation Carlsbad, CA 000000000 -
0000000 000000000 Venture Capital-Backed San Francisco, CA 00 000.00 0000000000 0 000.00
You’re viewing 5 of 18 competitors. Get the full list »

Genoskin Executive Team (1)

Name Title Board Seat Contact Info
Pascal Descargues Ph.D Founder & Chief Executive Officer
To view Genoskin’s complete executive team members history, request access »

Genoskin Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genoskin Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
North Shore InnoVentures Accelerator/Incubator Minority 000 0000 000000 0
Centre Pierre Potier Accelerator/Incubator Minority 000 0000 000000 0
OSEO Innovation Venture Capital Minority 000 0000 000000 0
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Genoskin’s complete investors history, request access »